Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eprazinone dihydrochloride (NSC 317935) is a mucolytic with antitussive and mucolytic effect.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 33.00 | |
100 mg | In stock | $ 54.00 | |
250 mg | In stock | $ 98.00 | |
500 mg | In stock | $ 173.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 37.00 |
Description | Eprazinone dihydrochloride (NSC 317935) is a mucolytic with antitussive and mucolytic effect. |
In vivo | Eprazinone 2HCl is a drug with proposed mucolytic, secretolytic, and bronchial antispasmodic properties. Eprazinone 2HCl improves pulmonary function and arterial pOO. Eprazinone also appears to have an antitussive and mucolytic effect. Eprazinone influences both bronchoalveolar lavage fluid (BAL) lipid levels and ion transport. [1] |
Synonyms | Resplen, Mucitux, Eftapan, NSC 317935, Eprazinone 2HCl |
Molecular Weight | 453.44 |
Formula | C24H32N2O2·2HCl |
CAS No. | 10402-53-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 10 mM(< means unknown)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eprazinone dihydrochloride 10402-53-6 GPCR/G Protein Neuroscience Others Neurokinin receptor chloride arterial transport Phospholipid Eprazinone Dihydrochloride NK receptor Inhibitor pulmonary Resplen Mucitux pO2 Eftapan Neurokinin Receptor NSC-317935 NSC 317935 NSC317935 antitussive inhibit antispasmodic secretolytic NK1R mucolytic Eprazinone 2HCl Eprazinone Tachykinin receptor inhibitor